LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
AEONCIK 0001837607

AEON Biopharma, Inc.

14 transactions by 11 insiders, from February 17, 2026 to August 19, 2026.

Transactions
1411 insiders
Bought · P
$243Kopen market
Sold · S
Nonenobody sold on the open market
Net
+$243Knet buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Alexander Blair WilsonOfficer2———
Jennifer SyOfficer2———
Chad OhCMO2———
Jost FischerDir1———
Eric G. CarterDir1———
John BencichCFO1———
Marc ForthDir1———
Robert J. PalmisanoDir1———
Robert E. BancroftCEO1———
Shelley B. ThunenDir1———

Large holders and funds

Holders above 10%, often funds. They file the same form, but they trade for portfolio reasons, not because of what they know.

InsiderTradesPlannedBoughtSold
Timothy P. Lynch10%1—$243K—

All transactions

14 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Timothy P. Lynch10%Aug 19P1,150,000$0.21$243K
Shelley B. ThunenDirJun 17A222,684$0.00—
Robert J. PalmisanoDirJun 17A222,684$0.00—
Marc ForthDirJun 17A222,684$0.00—
Jost FischerDirJun 17A222,684$0.00—
Eric G. CarterDirJun 17A222,684$0.00—
John BencichCFOApr 2A754,717$0.00—
Chad OhCMOMar 4A1,316,872$0.00—
Chad OhCMOFeb 17A862,500$0.00—
Alexander Blair WilsonOfficerMar 4A1,316,872$0.00—
Alexander Blair WilsonOfficerFeb 17A862,500$0.00—
Jennifer SyOfficerMar 4A925,925$0.00—
Jennifer SyOfficerFeb 17A575,000$0.00—
Robert E. BancroftCEOFeb 17A3,000,000$0.00—